| Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. | |
| | |
MedLine Citation:
|
PMID: 12052585 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Placenta percreta is a rare but potentially lethal condition. Previously described conservative measures to avoid life-threatening hemorrhage and preserve fertility include use of methotrexate and uterine artery embolization. CASE: A woman with suspected placenta percreta diagnosed on ultrasound in the second trimester was delivered by classic, fundal cesarean at 30 weeks' gestation for bleeding and premature rupture of membranes. The placenta was left in situ, and she was treated with methotrexate. Postpartum bleeding 1 week later was managed by internal iliac balloon catheterization and manual transcervical removal of the placenta, which resulted in hysterectomy and required massive blood transfusion. CONCLUSION: Placenta percreta managed conservatively with methotrexate and internal iliac balloon catheterization resulted in serious morbidity. |
| | |
Authors:
|
Kimberly Butt; Alain Gagnon; Marie France Delisle |
Related Documents
:
|
3943935 - Persistent right umbilical vein--case report and review of literature. 1748945 - How to assess fetal metabolic acidosis from cord samples. 21292285 - Bicuspid aortic valve surgery with proactive ascending aorta repair. 8542655 - Osteocalcin metabolism in late fetal life: fetal and maternal osteocalcin levels. 9167775 - Importance of management of unruptured cerebral aneurysms. 15311565 - Two cases of complications of the thrombolysis of right heart free-floating thrombi wit... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Obstetrics and gynecology Volume: 99 ISSN: 0029-7844 ISO Abbreviation: Obstet Gynecol Publication Date: 2002 Jun |
Date Detail:
|
Created Date: 2002-06-07 Completed Date: 2002-06-21 Revised Date: 2009-10-26 |
Medline Journal Info:
|
Nlm Unique ID: 0401101 Medline TA: Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 981-2 Citation Subset: AIM; IM |
Affiliation:
|
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortifacient Agents, Nonsteroidal* Adult Balloon Dilatation* Cesarean Section Female Fetal Membranes, Premature Rupture / therapy Humans Hysterectomy Iliac Vein / surgery Methotrexate* Placenta Accreta / therapy* Postpartum Hemorrhage / therapy* Pregnancy Pregnancy Trimester, Second Treatment Failure |
| Chemical | |
Reg. No./Substance:
|
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The likelihood of placenta previa with greater number of cesarean deliveries and higher parity.
Next Document: Microwave endometrial ablation versus endometrial resection: a randomized controlled trial.